The ability of phage-typing and SmaI chromosomal RFLPs to conclude appropriate strain relatedness between a collection of 12 well-characterized in vitro-selected vancomycin-intermediate Staphylococcus aureus (VISA) strains and their seven vancomycin-susceptible parent strains is reported. Generally, no SmaI RFLP alterations were observed in VISA strains when they were compared with their respective parent strains, and clonal relationships between isogenic strains were clearly evident. Unlike the SmaI RFLP results, parent strains and VISA derivatives generally did not share similar phage-typing profiles. Depending on the phage set investigated, some VISA strains even became untypable by this method. Loss of phage infectivity is probably due to cell wall (phage receptor) alterations that are expressed by the VISA strains investigated. Collectively, these findings indicate that inappropriate relationships between VISA and vancomycin-susceptible parents might be drawn if only phage-typing and antibiotic susceptibility are utilized to determine epidemiological relationships.
AndrasevicA. T,
PowerE. G,
AnthonyR. M,
KalenicS,
FrenchG. L.1999; Failure of bacteriophage typing to detect an inter-hospital outbreak of methicillin-resistant Staphylococcus aureus (MRSA) in Zagreb subsequently identified by random amplification of polymorphic DNA (RAPD) and pulsed-field gel electrophoresis (PFGE). Clin Microbiol Infect 5:634–642[CrossRef]
AvisonM. B,
BennettP. M,
HoweR. A,
WalshT. R.2002; Preliminary analysis of the genetic basis for vancomycin resistance in Staphylococcus aureus strain Mu50. J Antimicrob Chemother 49:255–260[CrossRef]
ChatterjeeA. N.1969; Use of bacteriophage-resistant mutants to study the nature of bacteriophage receptor site of Staphylococcus aureus . J Bacteriol 98:519–527
ChesneauO,
MorvanA,
El SolhN.2000; Retrospective screening for heterogeneous vancomycin resistance in diverse Staphylococcus aureus clones disseminated in French hospitals. J Antimicrob Chemother 45:887–890[CrossRef]
DaiG,
SuP,
AllisonG. E,
GellerB. L,
ZhuP,
KimW. S,
DunnN. W.2001; Molecular characterization of a new abortive infection system (AbiU) from Lactococcus lactis LL51–1. Appl Environ Microbiol 67:5225–5232[CrossRef]
DaumR. S,
GuptaS,
SabbaghR,
MilewskiW. M.1992; Characterization of Staphylococcus aureus isolates with decreased susceptibility to vancomycin and teicoplanin: isolation and purification of a constitutively produced protein associated with decreased susceptibility. J Infect Dis 166:1066–1072[CrossRef]
HiramatsuK,
AritakaN,
HanakiH,
KawasakiS,
HosodaY,
HoriS,
FukuchiY,
KobayashiI.1997b; Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350:1670–1673[CrossRef]
KimM. N,
HwangS. H,
PyoY. J,
MunH. M,
PaiC. H.2002; Clonal spread of Staphylococcus aureus heterogeneously resistant to vancomycin in a university hospital in Korea. J Clin Microbiol 40:1376–1380[CrossRef]
KongJ,
JosephsenJ.2002; The ability of the plasmid-encoded restriction and modification system Lla BII to protect Lactococcus lactis against bacteriophages. Lett Appl Microbiol 34:249–253[CrossRef]
McGrathS,
FitzgeraldG. F,
van SinderenD.2002; Identification and characterization of phage-resistance genes in temperate lactococcal bacteriophages. Mol Microbiol 43:509–520[CrossRef]
O'NeillG. L,
MurchanS,
Gil-SetasA,
AuckenH. M.2001; Identification and characterization of phage variants of a strain of epidemic methicillin-resistant Staphylococcus aureus (EMRSA-15). J Clin Microbiol 39:1540–1548[CrossRef]
RiepertA,
EhlertK,
KastT,
BierbaumG.2003; Morphological and genetic differences in two isogenic Staphylococcus aureus strains with decreased susceptibilities to vancomycin. Antimicrob Agents Chemother 47:568–576[CrossRef]
SchaaffF,
ReipertA,
BierbaumG.2002; An elevated mutation frequency favors development of vancomycin resistance in Staphylococcus aureus . Antimicrob Agents Chemother 46:3540–3548[CrossRef]
SieradskiK,
RobertsR. B,
HaberS. W,
TomaszA.1999a; The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. N Engl J Med 340:517–523[CrossRef]
SieradzkiK,
WuS. W,
TomaszA.1999b; Inactivation of the methicillin resistance gene mecA in vancomycin-resistant Staphylococcus aureus . Microb Drug Resist 5:253–257[CrossRef]
SimorA. E,
Ofner-AgostiniM,
BryceE,
McGeerA,
PatonS,
MulveyM. R.2002; Laboratory characterization of methicillin-resistant Staphylococcus aureus in Canadian hospitals: results of 5 years of National Surveillance. J Infect Dis 186:652–660[CrossRef]
SmithT. L,
PearsonM. L,
WilcoxK. R.8 other authors1999; Emergence of vancomycin resistance in Staphylococcus aureus .Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl J Med 340:493–501[CrossRef]
TambicA,
PowerE. G,
TalsaniaH,
AnthonyR. M,
FrenchG. L.1997; Analysis of an outbreak of non-phage-typeable methicillin-resistant Staphylococcus aureus by using a randomly amplified polymorphic DNA assay. J Clin Microbiol 35:3092–3097
TranH. L,
FiedlerF,
HodgsonD. A,
KathariouS.1999; Transposon-induced mutations in two loci of Listeria monocytogenes serotype 1/2a result in phage resistance and lack of N -acetylglucosamine in the teichoic acid of the cell wall. Appl Environ Microbiol 65:4793–4798